Last reviewed · How we verify

NCT04133701

Meal Timing and Blood Pressure

Completed NA Last updated 22 March 2023
What this trial tests

NA trial testing Time-Restricted Feeding in Blood Pressure in 34 participants. Completed in 16 December 2022.

Timeline
2 February 2022
Primary endpoint
16 December 2022
16 December 2022

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment34
Start date2 February 2022
Primary completion16 December 2022
Estimated completion16 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

Adults 50 to 65, any sex, with Blood Pressure or Neurovascular Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing the time in which the participant consumes food each day.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Time-Restricted Feeding

Trials testing the same drug.

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04133701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing